Active Wellness: Search, Learn & Order Drugs with ActiveMED

100 mg, Capsules
Manufacture: SUN
Rating:

98.00
Qty:
IN STOCK

Substitutes

Add Another Drug

Brand Name	Price	Pack	Save (₹)	Manufacturer
Cap, ANDROFIL TESTOCAP Comp: (Testosterone Undeconate 40mg )	89.00	10	-9.00	CIPLA
Cap, CERNOS Comp: (Testosterone Undeconate 40mg )	98.00	10	+0.00	SUN
Cap, NUVIR Comp: (Testosterone Undeconate 40mg )	290.00	30	+192.00	ORGANON INDIA LTD
Cap, TESTOFIL DEPOT Comp: (Testosterone Undeconate 250 mg )	612.00	10	+514.00	CADILA

Description

It is secreted from leydig cell of testes. It is responsible for development of secondary sex characters in boys at time of puberty and subsequent maintenance of spermatogenesis during reproductive life of males. It produces anabolic effects.

Indications

Carcinoma Breast
Delayed Puberty
Hereditary angioneurotic edema
Hypogonadism, Primary and Secondary
Senile Osteoporosis

Side Effects

Acne
Cholestatic Jaundice
Gynaecomastia in Males (increased production of prolactin)
Increased incident of hepatic adrenocarcinoma
Oedema
Oligospermia
Precocious puberty in boys
Virilisation (male features such as beard ) females

Precautions

Hypertension

Contraindications

Disease Of Liver
Kidney disease
Pregnancy
Prostate Carcinoma

Interactions

Interact Type	Severity
Increases effect Abciximab
Increases effect Acarbose
Increases effect Acenocoumarol
Increases effect Acetohexamide
Increases effect Acetylsalicylic Acid
Increases effect Aloxiprin
Increases effect Alteplase
Increases effect Ancrod
Increases effect Anistreplase
Increases effect Antithrombin Iii
Increases effect Apixaban
Increases effect Argatroban
Increases effect Bemiparin
Increases effect Beraprost
Increases effect Bivalirudin
Increases effect Brinase
Increases effect Carbasalate Calcium
Increases effect Carbutamide
Increases effect Chlorpropamide
Increases effect Cilostazol
Increases effect Clopidogrel
Increases effect Cloricromen
Increases effect Clorindione
Increases effect Combinations
Increases effect Dabigatran Etexilate
Increases effect Dalteparin
Increases effect Danaparoid
Increases effect Defibrotide
Increases effect Dermatan Sulfate
Increases effect Desirudin
Increases effect Dicoumarol
Increases effect Diphenadione
Increases effect Dipyridamole
Increases effect Ditazole
Increases effect Drotrecogin Alfa (Activated)
Increases effect Enoxaparin
Increases effect Epoprostenol
Increases effect Eptifibatide
Increases effect Ethyl Biscoumacetate
Increases effect Fibrinolysin
Increases effect Fondaparinux
Increases effect Glibenclamide
Increases effect Glibornuride
Increases effect Gliclazide
Increases effect Glimepiride
Increases effect Glipizide
Increases effect Gliquidone
Increases effect Glisoxepide
Increases effect Heparin
Increases effect Heparin, Combinations
Increases effect Combinations
Increases effect Iloprost
Increases effect Indobufen
Increases effect Lepirudin
Increases effect Melagatran
Increases effect Metahexamide
Increases effect Metformin
Increases effect Miglitol
Increases effect Nadroparin
Increases effect Parnaparin
Increases effect Phenindione
Increases Metabolism Phenobarbital
Increases effect Phenprocoumon
Increases effect Picotamide
Increases effect Pioglitazone
Increases effect Prasugrel
Increases effect Protein C
Increases effect Reteplase
Increases effect Reviparin
Increases Metabolism Rifampicin
Increases effect Rivaroxaban
Increases effect Saruplase
Increases effect Streptokinase
Increases effect Sulodexide
Increases effect Tenecteplase
Increases effect Ticagrelor
Increases effect Ticlopidine
Increases effect Tinzaparin
Increases effect Tioclomarol
Increases effect Tirofiban
Increases effect Tolazamide
Increases effect Tolbutamide
Increases effect Treprostinil
Increases effect Triflusal
Increases effect Troglitazone
Increases effect Urokinase
Increases effect Voglibose
Increases effect Warfarin
Increases effect Ximelagatran

Consumption Details

Route/Form	Dose	Age	Days
Intramuscular/ Injectible	50 mg	Male Adult	2 weeks

Safety in pregnancy

Testosterone (CERNOS) falls in Category X

Pregnancy Category	Description
Category X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience; and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits
Category X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience; and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits
Category X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience; and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits
Category X	Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience; and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits

Testosterone (CERNOS)